CLINICAL_TRIALS
trial_result
· 2019-04-23
Clinical Trial Update: Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome [Phase 2]
Summary
Phase 2 trial exploring auranofin for reducing pain in paclitaxel-induced pain syndrome; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Pain | Phase 2 | Status: COMPLETED | Results posted: 2019-04-23